Immunoglobulin-responsive chikungunya encephalitis: two case reports
- 229 Downloads
Chikungunya virus is an alphavirus transmitted by the mosquito Aedes, mainly Aedes aegypti and Aedes albopictus, that can cause acute illness, mostly self-limited, characterized by fever, maculopapular rash, and disabling polyarthritis/arthralgia, with an incubation period of 1 to 12 days. Chikungunya was largely regarded as a non-fatal and self-limited disease, but recently, serious cases have been reported including some with severe involvement of the nervous system, such as meningoencephalitis, myelitis, polyradiculitis, and polyradiculoneuropathy. In this report, we describe the clinical and laboratory findings of two patients with encephalitis associated with chikungunya in a northeastern city in Brazil, who exhibited a good outcome, with improvement after treatment with i.v. immunoglobulin (IVIg).
KeywordsEncephalitis Chikungunya Immunoglobulin Treatment
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Azevedo RSS, Oliveira CS, Vasconcelos PFC (2015) Risco do Chikungunya para o Brasil. Rev Saude Publica 49Google Scholar
- Donalisio MR, Freitas AR (2015) Chikungunya in Brasil: an emerging challenge. Rev Bras Epidemiol 18(1)Google Scholar
- Ganesan K, Diwan A, Shankar SK, Desai SB, Saiani GS, Katrak SM (2008) Chikungunya encephalomyeloradiculitis: report of 2 cases with neuroimaging and 1 case with autopsy findings. AJNR 29Google Scholar
- Gérardin P, Couderc T, Bintner M, Tournebize P, Renouil M, Lémant J, Boisson V, Borguerini G, Staikowsky F, Schramm F, Lecuit M, Michault A (2015) Chikungunya virus-associated encephalitis. Neurology 86Google Scholar
- Ziegler SA, Lu L, da Rosa AP, Xiao SY, Tesh RB (2008) An animal model for studying the pathogenesis of chikungunya virus infection. AmJTrop Med Hyg 79:133–139Google Scholar